Madurai, Oct 08: Thyrocare Technologies Limited, a healthcare diagnostics company in India, to have achieved 100% NABL accreditation across all its laboratories, has announced the launch of its new diagnostic laboratory in Madurai, Tamil Nadu. The facility was inaugurated by Mr Rahul Guha, Managing Director & CEO, Thyrocare and API Holdings. The launch marks another step in Thyrocare’s efforts to strengthen its diagnostic network and improve access to reliable and affordable diagnostic services across emerging markets.
The new laboratory is equipped to cater to routine as well as specialised diagnostic testing requirements and is supported by trained professionals and Thyrocare’s technology-enabled diagnostic processes. The facility is expected to support the growing healthcare needs of patients, laboratories and healthcare partners across Madurai and the surrounding regions.
The expansion strengthens Thyrocare’s local presence in Tamil Nadu and enables greater access to its diagnostic services, supported by standardised processes, timely sample processing and reliable reporting. The launch is also aligned with the company’s continued focus on expanding its network beyond key metropolitan markets and bringing quality diagnostic services closer to patients.
Sharing his thoughts on the launch, Mr Rahul Guha, Managing Director & CEO, Thyrocare and API Holdings, said,
“At Thyrocare, our focus has always been on making quality and trustworthy diagnostic services more accessible to people across India. The launch of our new laboratory in Madurai is another step towards strengthening our presence in emerging markets and bringing our technology-led diagnostic capabilities closer to patients. We remain committed to building a wider diagnostic network that combines affordability, quality and accessibility to support both ongoing and preventive healthcare needs.”
Speaking on the occasion, Dr Ramesh Kinha, Chief Operating Officer, Thyrocare, said,
“The launch of our new laboratory in Madurai strengthens our ability to serve the diagnostic needs of the city and the surrounding regions. The facility will support a comprehensive range of routine and specialised testing, backed by Thyrocare’s standardised processes, technology and quality protocols. By establishing a stronger local diagnostic presence, we can enable efficient sample processing and timely reporting while bringing reliable and affordable testing closer to patients and healthcare partners. This laboratory is an important part of our continued efforts to expand access to quality diagnostics across Tamil Nadu and the wider southern region.”
With the launch of its new laboratory in Madurai, Thyrocare continues to strengthen its diagnostic footprint across India, with a focus on expanding access to standardised and affordable testing beyond the metro markets.
